carbostyril has been researched along with Orphan Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooney, D | 1 |
| Amaral, MD | 1 |
| Bendstrup, E; Hilberg, O; Jensen, ML | 1 |
1 review(s) available for carbostyril and Orphan Diseases
| Article | Year |
|---|---|
Novel personalized therapies for cystic fibrosis: treating the basic defect in all patients.
Topics: Aminoglycosides; Aminophenols; Anti-Bacterial Agents; Anti-Inflammatory Agents; Biomarkers; Codon, Nonsense; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Evidence-Based Medicine; Frameshift Mutation; Genistein; Humans; Oxadiazoles; Phenotype; Precision Medicine; Purinergic Antagonists; Quinolones; Rare Diseases; Severity of Illness Index; Sweat Glands | 2015 |
2 other study(ies) available for carbostyril and Orphan Diseases
| Article | Year |
|---|---|
New cystic fibrosis drug paves the way for orphan diseases.
Topics: Aminophenols; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Approval; Drug Costs; Humans; Mutation; Precision Medicine; Quinolones; Rare Diseases; Respiratory System Agents; United Kingdom | 2013 |
Granulomatous-lymphocytic interstitial lung disease and recurrent sinopulmonary infections in a patient with Good's syndrome.
Topics: Adult; Agammaglobulinemia; Anti-Bacterial Agents; Cephalosporins; Granuloma; Haemophilus Infections; Haemophilus influenzae; Humans; Immunologic Deficiency Syndromes; Lung Diseases, Interstitial; Male; Neoplasms, Glandular and Epithelial; Pivampicillin; Pneumocystis carinii; Pneumocystis Infections; Quinolones; Rare Diseases; Thymoma; Thymus Neoplasms | 2015 |